APOTEX CORPORATION

Lobbying client · Florida · filed 2025 to 2026

Generic pharmaceutical manufacturer

$130,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (203130), not by name.

Firms hired 1

GOVERNMENT COUNSEL, LLC $130,000 6 filings

Reported by year 2 years

2026 $50,000 2 filings
2025 $80,000 4 filings

Issues lobbied 1

Manufacturing 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q2

GOVERNMENT COUNSEL, LLC

2nd Quarter (Apr 1 - June 30) 2026 · $30,000 income · posted Jul 20, 2026

View → Q1

GOVERNMENT COUNSEL, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 income · posted Apr 17, 2026

View → Q4

GOVERNMENT COUNSEL, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $20,000 income · posted Jan 19, 2026

View → Q3

GOVERNMENT COUNSEL, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 income · posted Oct 2, 2025

View → Q2

GOVERNMENT COUNSEL, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Jul 9, 2025

View → Q1

GOVERNMENT COUNSEL, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $20,000 income · posted Apr 13, 2025

View →

Foreign entities disclosed 1

APOTEX INC. Canada named on 1 filing · highest disclosed ownership 0% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.